Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2574 | 2205 | 36.2 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
597 | 3 | CYSTIC FIBROSIS//CFTR//JOURNAL OF CYSTIC FIBROSIS | 14714 |
542 | 2 | CYSTIC FIBROSIS//CFTR//JOURNAL OF CYSTIC FIBROSIS | 14714 |
2574 | 1 | CYSTIC FIBROSIS//PULMONARY EXACERBATION//JOURNAL OF CYSTIC FIBROSIS | 2205 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CYSTIC FIBROSIS | authKW | 1173924 | 40% | 10% | 879 |
2 | PULMONARY EXACERBATION | authKW | 454367 | 3% | 58% | 57 |
3 | JOURNAL OF CYSTIC FIBROSIS | journal | 359870 | 7% | 16% | 159 |
4 | RHDNASE | authKW | 284480 | 1% | 62% | 33 |
5 | INHALED ANTIBIOTICS | authKW | 276045 | 2% | 55% | 36 |
6 | DORNASE ALFA | authKW | 222842 | 1% | 62% | 26 |
7 | TOBRAMYCIN | authKW | 216892 | 4% | 19% | 82 |
8 | PEDIATRIC PULMONOLOGY | journal | 213401 | 12% | 6% | 269 |
9 | INHALED TOBRAMYCIN | authKW | 142417 | 1% | 86% | 12 |
10 | PSEUDOMONAS AERUGINOSA | authKW | 112116 | 10% | 4% | 228 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Respiratory System | 70593 | 46% | 1% | 1023 |
2 | Pediatrics | 13024 | 27% | 0% | 592 |
3 | Critical Care Medicine | 3976 | 9% | 0% | 189 |
4 | Infectious Diseases | 1478 | 8% | 0% | 185 |
5 | Pharmacology & Pharmacy | 890 | 14% | 0% | 309 |
6 | Medicine, General & Internal | 746 | 10% | 0% | 221 |
7 | Microbiology | 608 | 8% | 0% | 183 |
8 | Allergy | 145 | 1% | 0% | 31 |
9 | Health Care Sciences & Services | 80 | 2% | 0% | 38 |
10 | Radiology, Nuclear Medicine & Medical Imaging | 72 | 4% | 0% | 78 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CHILD HLTH OBSTET GYNAECOL COG | 71209 | 0% | 86% | 6 |
2 | CYST FIBROSIS | 61261 | 3% | 7% | 64 |
3 | CYST FIBROSIS FDN THER EUT DEV NETWORK COORDINAT | 55386 | 0% | 100% | 4 |
4 | PEDIAT PULMONOL ALLERGOL | 54635 | 1% | 26% | 15 |
5 | PEDIAT PULMONOL | 44726 | 3% | 5% | 61 |
6 | LUNG INFLAMMAT INFECT GRP | 41539 | 0% | 100% | 3 |
7 | PEDIAT PULMONOL RADIOL | 41539 | 0% | 100% | 3 |
8 | PIROLLI KA SHING KNOWLEDGE | 41539 | 0% | 100% | 3 |
9 | SECT PEDIAT PULMONOL ALLERGY SLEEP MED | 38338 | 0% | 46% | 6 |
10 | PAEDIAT P MED | 36482 | 2% | 8% | 34 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CYSTIC FIBROSIS | 359870 | 7% | 16% | 159 |
2 | PEDIATRIC PULMONOLOGY | 213401 | 12% | 6% | 269 |
3 | THORAX | 12728 | 4% | 1% | 81 |
4 | PAEDIATRIC RESPIRATORY REVIEWS | 11297 | 1% | 4% | 22 |
5 | AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 7962 | 3% | 1% | 75 |
6 | JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY | 7022 | 1% | 4% | 14 |
7 | CURRENT OPINION IN PULMONARY MEDICINE | 6993 | 1% | 2% | 25 |
8 | EXPERT REVIEW OF RESPIRATORY MEDICINE | 6466 | 1% | 3% | 14 |
9 | EUROPEAN RESPIRATORY JOURNAL | 5978 | 3% | 1% | 63 |
10 | JOURNAL OF PEDIATRICS | 5083 | 3% | 1% | 71 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYSTIC FIBROSIS | 1173924 | 40% | 10% | 879 | Search CYSTIC+FIBROSIS | Search CYSTIC+FIBROSIS |
2 | PULMONARY EXACERBATION | 454367 | 3% | 58% | 57 | Search PULMONARY+EXACERBATION | Search PULMONARY+EXACERBATION |
3 | RHDNASE | 284480 | 1% | 62% | 33 | Search RHDNASE | Search RHDNASE |
4 | INHALED ANTIBIOTICS | 276045 | 2% | 55% | 36 | Search INHALED+ANTIBIOTICS | Search INHALED+ANTIBIOTICS |
5 | DORNASE ALFA | 222842 | 1% | 62% | 26 | Search DORNASE+ALFA | Search DORNASE+ALFA |
6 | TOBRAMYCIN | 216892 | 4% | 19% | 82 | Search TOBRAMYCIN | Search TOBRAMYCIN |
7 | INHALED TOBRAMYCIN | 142417 | 1% | 86% | 12 | Search INHALED+TOBRAMYCIN | Search INHALED+TOBRAMYCIN |
8 | PSEUDOMONAS AERUGINOSA | 112116 | 10% | 4% | 228 | Search PSEUDOMONAS+AERUGINOSA | Search PSEUDOMONAS+AERUGINOSA |
9 | RECOMBINANT HUMAN DEOXYRIBONUCLEASE | 96925 | 0% | 100% | 7 | Search RECOMBINANT+HUMAN+DEOXYRIBONUCLEASE | Search RECOMBINANT+HUMAN+DEOXYRIBONUCLEASE |
10 | PSEUDOMONAS INFECTIONS DRUG THERAPY | 93459 | 0% | 75% | 9 | Search PSEUDOMONAS+INFECTIONS+DRUG+THERAPY | Search PSEUDOMONAS+INFECTIONS+DRUG+THERAPY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HURLEY, MN , PRAYLE, AP , FLUME, P , (2015) INTRAVENOUS ANTIBIOTICS FOR PULMONARY EXACERBATIONS IN PEOPLE WITH CYSTIC FIBROSIS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 7. P. - | 91 | 77% | 2 |
2 | HEWER, SCL , SMYTH, AR , (2014) ANTIBIOTIC STRATEGIES FOR ERADICATING PSEUDOMONAS AERUGINOSA IN PEOPLE WITH CYSTIC FIBROSIS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 11. P. - | 71 | 87% | 5 |
3 | CANTON, R , MAIZ, L , ESCRIBANO, A , OLVEIRA, C , OLIVER, A , ASENSIO, O , GARTNER, S , ROMA, E , QUINTANA-GALLEGO, E , SALCEDO, A , ET AL (2015) SPANISH CONSENSUS ON THE PREVENTION AND TREATMENT OF PSEUDOMONAS AERUGINOSA BRONCHIAL INFECTIONS IN CYSTIC FIBROSIS PATIENTS.ARCHIVOS DE BRONCONEUMOLOGIA. VOL. 51. ISSUE 3. P. 140 -150 | 81 | 70% | 1 |
4 | TALWALKAR, JS , MURRAY, TS , (2016) THE APPROACH TO PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS.CLINICS IN CHEST MEDICINE. VOL. 37. ISSUE 1. P. 69 -+ | 57 | 80% | 3 |
5 | BUSH, A , CAMPBELL, PW , CATTANEO, A , DEMBOWSKY, K , DREVINEK, P , DUBOIS, C , EICHLER, I , ELBORN, JS , FLUME, PA , FOWERAKER, JE , ET AL (2012) TREATMENT OF LUNG INFECTION IN PATIENTS WITH CYSTIC FIBROSIS: CURRENT AND FUTURE STRATEGIES.JOURNAL OF CYSTIC FIBROSIS. VOL. 11. ISSUE 6. P. 461 -479 | 69 | 55% | 116 |
6 | LANGAN, KM , KOTSIMBOS, T , PELEG, AY , (2015) MANAGING PSEUDOMONAS AERUGINOSA RESPIRATORY INFECTIONS IN CYSTIC FIBROSIS.CURRENT OPINION IN INFECTIOUS DISEASES. VOL. 28. ISSUE 6. P. 547 -556 | 59 | 74% | 6 |
7 | FLUME, PA , VANDEVANTER, DR , (2015) CLINICAL APPLICATIONS OF PULMONARY DELIVERY OF ANTIBIOTICS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 85. ISSUE . P. 1 -6 | 56 | 73% | 9 |
8 | DAS, RR , KABRA, SK , SINGH, M , (2013) TREATMENT OF PSEUDOMONAS AND STAPHYLOCOCCUS BRONCHOPULMONARY INFECTION IN PATIENTS WITH CYSTIC FIBROSIS.SCIENTIFIC WORLD JOURNAL. VOL. . ISSUE . P. - | 58 | 81% | 1 |
9 | LAHIRI, T , HEMPSTEAD, SE , BRADY, C , CANNON, CL , CLARK, K , CONDREN, ME , GUILL, MF , GUILLERMAN, RP , LEONE, CG , MAGUINESS, K , ET AL (2016) CLINICAL PRACTICE GUIDELINES FROM THE CYSTIC FIBROSIS FOUNDATION FOR PRESCHOOLERS WITH CYSTIC FIBROSIS.PEDIATRICS. VOL. 137. ISSUE 4. P. - | 68 | 52% | 3 |
10 | DA SILVA, LVRF , FERREIRA, FD , REIS, FJC , DE BRITTO, MCA , LEVY, CE , CLARK, O , RIBEIRO, JD , (2013) PSEUDOMONAS AERUGINOSA INFECTION IN PATIENTS WITH CYSTIC FIBROSIS: SCIENTIFIC EVIDENCE REGARDING CLINICAL IMPACT, DIAGNOSIS, AND TREATMENT.JORNAL BRASILEIRO DE PNEUMOLOGIA. VOL. 39. ISSUE 4. P. 495-512 | 63 | 72% | 3 |
Classes with closest relation at Level 1 |